FENOFIBRATE SANDOZ (Sandoz Pty Ltd)
Product name
FENOFIBRATE SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
32 working days (45)
Active ingredients
fenofibrate
Registration type
EOI
Indication
Generic Medicine
FENOFIBRATE SANDOZ (film coated tablet) is now also indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy.
FENOFIBRATE SANDOZ does not replace the appropriate control of blood pressure, blood glucose and blood lipids in reducing the progression of diabetic retinopathy.